D

Dianthus Therapeutics
D

DNTH

102.820
USD
-2.92
(-2.76%)
قبل الجلسة·102.010USD-0.810(-0.79%)
حجم التداول
8
الربح لكل سهم
-5
العائد الربحي
-
P/E
-24
حجم السوق
5,620,782,077
المقالات
المزيد

العنوان: Dianthus Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.